Literature DB >> 7487687

Outpatient liver biopsy using ultrasound guidance and the Biopty gun is safe and cost effective.

B C Smith1, P V Desmond.   

Abstract

BACKGROUND: The need for liver biopsy is increasing with the increasing availability of treatments for liver disease, in particular interferon. For this reason the procedure must be efficient and economical, as well as safe. AIMS: Firstly to assess the safety of outpatient liver biopsy when performed with ultrasound guidance and the 'Biopty' gun. Secondly, to compare the cost of an outpatient and inpatient procedure.
METHODS: Two hundred and fifty consecutive liver biopsies performed over a two year period at St Vincent's Hospital, Melbourne were reviewed retrospectively. Indications, histological findings and complications were recorded.
RESULTS: Seventy per cent of the biopsies were performed as an outpatient procedure. There were no major complications. Four patients experienced prolonged pain post biopsy. The average cost for an outpatient biopsy was $351, the cost of an inpatient (overnight stay) was $690.
CONCLUSION: Outpatient liver biopsy is safe and cost effective, with minor complications in 1.6%. The routine use of ultrasound guidance and the Biopty gun is likely to contribute to these favourable results.

Entities:  

Mesh:

Year:  1995        PMID: 7487687     DOI: 10.1111/j.1445-5994.1995.tb01524.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  4 in total

Review 1.  Liver biopsy: when, how, by whom, and where?

Authors:  D B McGill
Journal:  Curr Gastroenterol Rep       Date:  2001-02

2.  Percutaneous liver biopsy using an ultrasound-guided subcostal route.

Authors:  P Rossi; P Sileri; P Gentileschi; G S Sica; A Forlini; V M Stolfi; A De Majo; G Coscarella; S Canale; A L Gaspari
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

3.  Who should be performing liver biopsies?

Authors:  C N Ghent
Journal:  Can J Gastroenterol       Date:  2009-06       Impact factor: 3.522

4.  Outpatient blind percutaneous liver biopsy in infants and children: is it safe?

Authors:  Mortada H El-Shabrawi; Hanaa M El-Karaksy; Sawsan H Okahsa; Naglaa M Kamal; Gamal El-Batran; Khaled A Badr
Journal:  Saudi J Gastroenterol       Date:  2012 Jan-Feb       Impact factor: 2.485

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.